Using a potassium‑competitive acid blocker after PCI to protect the stomach.
Official title: Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.
Run by Samsung Medical Center · NCT07068490 · Data updated 2026-11-12
We will see if giving a potassium‑competitive acid blocker instead of a proton pump inhibitor helps prevent stomach bleeding in people who had PCI and are taking dual antiplatelet medicines.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100000 (estimated) |
| Sponsor | Samsung Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | October 22, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | July 16, 2025 |
| Trial ID | NCT07068490 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People who underwent PCI, are taking aspirin plus clopidogrel, prasugrel, or ticagrelor, and who have not used a P‑CAB, PPI, or H2 blocker in the past month are eligible.
✕Probably not a fit
Patients who are already prescribed a PPI because of their bleeding risk or those with high GI bleeding risk who are not taking a PPI (and thus were excluded) are unlikely to benefit from enrollment in this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational target‑trial emulation comparing routine use of potassium‑competitive acid blockers (P‑CABs) versus guideline‑directed proton pump inhibitor (PPI) use for gastrointestinal protection in patients who underwent percutaneous coronary intervention (PCI) and remain on dual antiplatelet therapy (DAPT). The study uses real‑world clinical data from Samsung Medical Center to compare efficacy (GI bleeding prevention) and safety (including cardiovascular events) between the two approaches. Researchers will apply statistical methods to emulate a randomized trial and adjust for confounding factors such as baseline bleeding risk and concomitant medications. Outcomes will include rates of GI bleeding, major adverse cardiovascular events, and other safety endpoints during follow‑up.
Why it matters
Potential benefit: If successful, this approach could offer equal or better stomach protection for PCI patients on DAPT with comparable cardiovascular safety, potentially reducing GI bleeding and related hospital visits.
How similar studies have gone: Previous trials show P‑CABs provide stronger acid suppression than PPIs, but there is limited direct evidence on GI bleeding or cardiovascular outcomes in patients on DAPT, so this clinical application remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent PCI * Use of either clopidogrel, prasugrel, or ticagrelor in combination with aspirin * No use of PCAB, PPI, or an H2-receptor within the past month Exclusion Criteria: * Patients with low GI bleeding risk are taken on PPI * Patients with high GI bleeding risk do not take PPI
Where it's running
-
Samsung Medical Center
Seoul, South Korea Recruiting
Study contacts
- Principal investigator: KI HONG CHOI, MD, PhD — Samsung Medical Center
- Study coordinator: Ki Hong Choi, MD, PhD
- Email: cardiokh@gmail.com
- Phone: 82-2-3410-3419
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.